Brief: Oncopeptides Says Rescinds Voluntary Withdrawal Of Pepaxto In The U.S.
Jan 21 (Reuters) - Oncopeptides AB ONCO.ST :
* ONCOPEPTIDES RESCINDS VOLUNTARY WITHDRAWAL OF PEPAXTO IN
THE US
- NO INTENT TO MARKET IN THE US AT THIS TIME
* ONCOPEPTIDES AB - COMPANY HAS INITIATED A DIALOGUE WITH
FDA TO
REVIEW NEW DATA
Source text for Eikon: ID:nWkr8dVvz0
Further company coverage: ONCO.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncopeptides AB
See all newsSweden's Oncopeptides Q3 net sales rise on Pepaxti demand
Brief: Oncopeptides Q3 Operating Profit SEK -36.47 Million
Brief: Oncopeptides Completes Directed Share Issue Of SEK 100 Mln
Brief: Oncopeptides Confirms Blood-Brain-Barrier Penetration In Glioblastoma Study
Swedish biotech Oncopeptides' Q2 net sales rise on strong demand in Italy